Zhanjun Guo
Impact in
- Cancer Research top 5%
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
- Clinical Biochemistry top 5%
Papers in
-
- Mitochondrial Function and Pathology 28
- RNA modifications and cancer 23
- DNA Repair Mechanisms 10
- ATP Synthase and ATPases Research 8
-
- MicroRNA in disease regulation 16
- Cancer-related molecular mechanisms research 14
- Co-authors
- Cui-ju Wang (18 shared papers)Ruixing Zhang (17 shared papers)Yufei Zhao (13 shared papers)Haiyan Fan (7 shared papers)Fengbin Zhang (7 shared papers)Xiaoling Wang (4 shared papers)Cuimin Ding (4 shared papers)Shengmian Li (4 shared papers)
- Journals
- OncoTargets and Therapy (7 papers)Scientific Reports (6 papers)Frontiers in Immunology (3 papers)BMC Cancer (3 papers)Tumor Biology (3 papers)
- Partner nations
- ChinaUnited StatesTaiwan
In The Last Decade
Zhanjun Guo
93 papers receiving 1.3k citations
Peers
Comparison fields: 5 of 83
- Cancer Research 433
- Clinical Biochemistry 93
- Molecular Biology 903
- Hepatology 95
- Geriatrics and Gerontology 34
Countries citing papers authored by Zhanjun Guo
This map shows the geographic impact of Zhanjun Guo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zhanjun Guo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zhanjun Guo more than expected).
Fields of papers citing papers by Zhanjun Guo
This network shows the impact of papers produced by Zhanjun Guo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zhanjun Guo. The network helps show where Zhanjun Guo may publish in the future.
Co-authors
The 25 scholars most cited alongside Zhanjun Guo, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 94 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | MiR-122 targets VEGFC in bladder cancer to inhibit tumor growth and angiogenesis. | 2016 | 62 |
| 2 | 2011 | 56 | |
| 3 | 2010 | 46 | |
| 4 | 2010 | 45 | |
| 5 | 2012 | 43 | |
| 6 | 2011 | 42 | |
| 7 | 2013 | 41 | |
| 8 | 2021 | 39 | |
| 9 | 2012 | 37 | |
| 10 | 2012 | 34 | |
| 11 | 2016 | 32 | |
| 12 | 2015 | 30 | |
| 13 | 2016 | 30 | |
| 14 | 2015 | 28 | |
| 15 | 2015 | 27 | |
| 16 | 2021 | 25 | |
| 17 | 2013 | 25 | |
| 18 | 2014 | 22 | |
| 19 | 2020 | 21 | |
| 20 | 2013 | 21 |
About Zhanjun Guo
Zhanjun Guo is a scholar working on Molecular Biology, Cancer Research, Pulmonary and Respiratory Medicine, Oncology and Epidemiology, having authored 94 papers that have together received 1.3k indexed citations. Recurring topics across this work include Mitochondrial Function and Pathology (28 papers), RNA modifications and cancer (23 papers), MicroRNA in disease regulation (16 papers), Cancer-related molecular mechanisms research (14 papers), DNA Repair Mechanisms (10 papers), Gastric Cancer Management and Outcomes (10 papers), Metabolism and Genetic Disorders (9 papers) and ATP Synthase and ATPases Research (8 papers). The work is most often cited by research in Cancer Research (433 citations), Clinical Biochemistry (93 citations), Molecular Biology (903 citations), Hepatology (95 citations) and Geriatrics and Gerontology (34 citations). Zhanjun Guo has collaborated with scholars based in China, United States and Taiwan. Frequent co-authors include Cui-ju Wang, Ruixing Zhang, Yufei Zhao, Haiyan Fan, Fengbin Zhang, Xiaoling Wang, Cuimin Ding, Shengmian Li, Ying Xie and Yanming Du. Their work appears in journals such as OncoTargets and Therapy, Scientific Reports, Frontiers in Immunology, BMC Cancer and Tumor Biology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.